Business Description
Purple Biotech Ltd
ISIN : IL0007650166
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 43.89 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.8 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 5.4 | |||||
3-Year Book Growth Rate | -33.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.56 | |||||
9-Day RSI | 38.59 | |||||
14-Day RSI | 38.6 | |||||
6-1 Month Momentum % | -43.47 | |||||
12-1 Month Momentum % | -67.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 2.2 | |||||
Cash Ratio | 2.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.6 | |||||
Shareholder Yield % | -9.72 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -47.51 | |||||
ROA % | -40.53 | |||||
ROIC % | -81.49 | |||||
ROC (Joel Greenblatt) % | -3481.73 | |||||
ROCE % | -46.47 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 2.19 | |||||
EV-to-EBIT | 0.06 | |||||
EV-to-Forward-EBIT | -0.03 | |||||
EV-to-EBITDA | 0.06 | |||||
EV-to-FCF | 0.04 | |||||
Price-to-Net-Current-Asset-Value | 2.46 | |||||
Price-to-Net-Cash | 2.46 | |||||
Earnings Yield (Greenblatt) % | 1761.54 | |||||
FCF Yield % | -144.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Purple Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | |||
EPS (TTM) (₪) | -0.336 | ||
Beta | 0 | ||
Volatility % | 56.48 | ||
14-Day RSI | 38.6 | ||
14-Day ATR (₪) | 0.015052 | ||
20-Day SMA (₪) | 0.21095 | ||
12-1 Month Momentum % | -67.28 | ||
52-Week Range (₪) | 0.178 - 0.776 | ||
Shares Outstanding (Mil) | 261.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Purple Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Purple Biotech Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Purple Biotech Ltd Frequently Asked Questions
What is Purple Biotech Ltd(XTAE:PPBT)'s stock price today?
When is next earnings date of Purple Biotech Ltd(XTAE:PPBT)?
Does Purple Biotech Ltd(XTAE:PPBT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |